In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug ...

A combination featuring Exelixis’ experimental drug zanzalintinib has beaten Bayer’s gastrointestinal cancer med Stivarga in ...

One of the earliest signs of stomach cancer can be pain or discomfort in the stomach area, especially in the morning. You ...

A terminally-ill woman who had to have her tongue rebuilt from her arm is set to face a 200-metre-high zip wire to raise money for charity.

In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects ...

David Muir shares 3D scans of Titanic that reveal new insight into its final moments ...